iBio, Inc. (NYSEMKT:IBIO – Get Free Report)’s stock price was down 0.7% on Wednesday . The company traded as low as $2.07 and last traded at $2.08. Approximately 124,710 shares traded hands during mid-day trading, an increase of 10% from the average daily volume of 113,212 shares. The stock had previously closed at $2.09.
iBio Trading Down 0.7 %
The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.91 and a current ratio of 0.91. The firm’s 50-day moving average price is $2.12 and its 200 day moving average price is $1.68.
About iBio
iBio, Inc, a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel.
Read More
- Five stocks we like better than iBio
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- CD Calculator: Certificate of Deposit Calculator
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Golden Cross Stocks: Pattern, Examples and Charts
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
